These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1838296)

  • 1. Central vasopressin receptors are upregulated by deoxycorticosterone acetate.
    Swords BH; Wyss JM; Berecek KH
    Brain Res; 1991 Sep; 559(1):10-6. PubMed ID: 1838296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
    Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
    Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoids modulate central angiotensin II receptors in rats.
    Wilson KM; Sumners C; Hathaway S; Fregly MJ
    Brain Res; 1986 Sep; 382(1):87-96. PubMed ID: 3768684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vasopressinergic activity following DOCA administration in the rat.
    Chen YF; Lindheimer MD; Oparil S
    Brain Res Bull; 1986 Jan; 16(1):93-8. PubMed ID: 3955390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in vascular vasopressin receptors and responsiveness in DOCA/NaCl-treated rats.
    Smith CD; Pearlmutter F; Szkrybalo M; Katovich MJ
    Clin Exp Hypertens A; 1988; 10(4):629-47. PubMed ID: 2968870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
    Trinder D; Phillips PA; Risvanis J; Stephenson JM; Johnston CI
    Hypertension; 1992 Oct; 20(4):569-74. PubMed ID: 1398892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H15-21. PubMed ID: 8342627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
    Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z
    Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of hypothalamic and plasma vasopressin in rats with deoxycorticosterone-acetate induced salt appetite.
    Saravia FE; Grillo CA; Ferrini M; Roig P; Lima AE; de Kloet ER; De Nicola AF
    J Steroid Biochem Mol Biol; 1999; 70(1-3):47-57. PubMed ID: 10529002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasopressin administration and deficiency upon 3H-AVP binding sites in the CNS and periphery during development.
    Szot P; Myers KM; Dorsa DM
    Peptides; 1992; 13(2):389-94. PubMed ID: 1409016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex.
    Rascher W; Lang RE; Taubitz M; Meffle H; Unger T; Ganten D; Gross F
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():153s-156s. PubMed ID: 7188584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
    Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
    J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats.
    Schiffrin EL; Gutkowska J; Genest J
    Am J Physiol; 1984 Apr; 246(4 Pt 2):H608-14. PubMed ID: 6326599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.